BiF-4 Insights – Deborah Brooks – Michael J. Fox Foundation

We want to de-risk ideas and help move them towards being taken into clinical trials.

We sometimes add money to company investments in order to make Phase 1 trials more robust than originally planned:

  • $4 million VC-funded trial, we incremented by $750k to fund neuro-imaging and extra doctor visit
    • In order to get more data out of the trial

We are almost filling the role of an early stage investor (in some cases).

Giving foundation money to drug companies must be a challenge for people giving money to the foundation to take, but we are pushing the envelope in order to do whatever we can to accelerate the finding of a cure.

For more information on the talk, go here.

Posted in

Braden Kelley

Braden Kelley is a Design Thinking, Innovation and Transformation Consultant, a popular innovation speaker and workshop leader, and helps companies use Human-Centered Change™ to beat the 70% change failure rate. He is the author of Charting Change from Palgrave Macmillan and Stoking Your Innovation Bonfire from John Wiley & Sons. Braden has been advising companies since 1996, while living and working in England, Germany, and the United States. Braden earned his MBA from top-rated London Business School. Follow him on Twitter and Linkedin.

NEVER MISS ANOTHER NEWSLETTER!

Categories

LATEST BLOGS

Cultivating food from the air we breathe: How decades-old NASA technology is still delivering disruptive tech today

By Dan Blacharski | June 29, 2021

The “Replicator” machine seen on the “Star Trek: The Next Generation” television series was imagined as a 24th century technology…

Read More

Il Sole 24 Ore and qiibee launch the first book ever made on Blockchain & NFT

By Francesco Pagano | June 23, 2021

The first book in the world made on blockchain, the first ‘decentralized’ discussion on leadership, completely shared and co-created with…

Read More

Leave a Comment